Can you take Metformin and Acarbose together?

Read Off Label doesn't make stack recommendations — see the disclaimer. Both compounds have individual mechanism, dose, and risk profiles documented on their respective pages; combining them is a clinical question that depends on the goal, indication, and other context.

Rankings / Comparisons

Metformin vs Acarbose

Two glucose-control drugs that have surfaced in longevity research; different mechanisms and side-effect profiles.

Reviewed by Read Off Label · How we grade

Bottom line

On the composite score, Metformin (B+, 7.2/10) edges out Acarbose (B-, 6.3/10) — but the right pick depends on the specific outcome you're optimising for.

Metformin

B+ 7.2/10

aka Glucophage, Glumetza, Fortamet, Riomet

Evidence: Strong (in T2D); Moderate observationally (non-diabetics); Preclinical (pure anti-aging) (8/10)
Benefit: Varies (5/10)
Risk: Low-Med (GI side effects; B12 deficiency with chronic use; lactic acidosis rare; may blunt exercise adaptations) (7/10 safety)
Legality: Rx (off-label for longevity)
Dose: 500-2000 mg/day PO; titrate from 500 mg with meals
Class: Prescription
Last reviewed: Jun 8, 2026

Read Off Label grades Metformin as B+ (7.2/10) based on strong evidence, variable benefit magnitude, and a low-med-risk safety profile.

UKPDS showed 36% reduction in all-cause mortality in T2D.

Typical use: 500-2000 mg/day PO; titrate from 500 mg with meals — Rx.

What it is

UKPDS showed 36% reduction in all-cause mortality in T2D. TAME trial ($75M, 3000 non-diabetic older adults) repeatedly delayed — FDA approved design but unfunded. 2019 Konopka data: may blunt exercise-induced mitochondrial adaptations.

Mechanism

Complex I mild inhibition → AMPK activation → mTOR inhibition; improved insulin sensitivity; possible gut microbiome effects; reduced hepatic gluconeogenesis

Full Metformin review →

Acarbose

B- 6.3/10

aka Precose, Glucobay

Evidence: Moderate (human glycemic control); Strong (rodent lifespan especially in males) (6/10)
Benefit: Med (Varies by gender) (5/10)
Risk: Low-Med (GI flatulence is common) (7/10 safety)
Legality: Rx (T2D); often OTC outside US
Dose: 25-100 mg TID with first bite of meals
Class: Prescription
Last reviewed: Jun 8, 2026

Read Off Label grades Acarbose as B- (6.3/10) based on moderate evidence, med benefit magnitude, and a low-med-risk safety profile.

ITP: extended male mouse lifespan by 22%, female by 5% — one of the most robust ITP findings.

Typical use: 25-100 mg TID with first bite of meals — Rx (T2D); often OTC outside US.

What it is

ITP: extended male mouse lifespan by 22%, female by 5% — one of the most robust ITP findings. Human longevity data is extrapolated from diabetes trials and Japanese cohort data. Cheap and well-tolerated if GI side effects are acceptable.

Mechanism

Inhibits intestinal alpha-glucosidases; slows carbohydrate digestion; blunts postprandial glucose spike; produces more favorable microbiome (SCFA production)

Full Acarbose review →

Common questions

Which is better, Metformin or Acarbose?: On the composite score, Metformin (B+, 7.2/10) edges out Acarbose (B-, 6.3/10) — but the right pick depends on the specific outcome you're optimising for.
What's the difference between Metformin and Acarbose?: Two glucose-control drugs that have surfaced in longevity research; different mechanisms and side-effect profiles.
Can you take Metformin and Acarbose together?: Read Off Label doesn't make stack recommendations — see the disclaimer. Both compounds have individual mechanism, dose, and risk profiles documented on their respective pages; combining them is a clinical question that depends on the goal, indication, and other context.

This is an independent synthesis of published research by a non-clinician. Comparison-page verdicts use the composite Read Off Label score as a tiebreaker, but the right pick for any given person depends on indication, context, and clinician input. See the full disclaimer and methodology.